FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, and represents methods of counteracting oncogenic activity of FGF19 in a subject and, in specific embodiments, methods for preventing or treating a disease, disorder or condition, such as FGF19-dependent disease, disorder or condition, or its symptoms.
EFFECT: treating FGF19-dependent disease, disorder or condition, or its symptoms.
21 cl, 51 dwg, 4 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS, APPLICATIONS AND METHODS OF TREATING METABOLIC DISORDERS AND DISEASES | 2012 |
|
RU2697762C2 |
| METHODS FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES | 2013 |
|
RU2675514C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING PEPTIDE VERSIONS, AND METHODS OF USING THEM | 2015 |
|
RU2729161C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING METABOLIC SYNDROME | 2011 |
|
RU2593960C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING METABOLIC SYNDROME | 2011 |
|
RU2732703C2 |
| ADENO-ASSOCIATED VIRUS VECTOR | 2015 |
|
RU2743382C2 |
| TREATMENT OF LIVER, BILE DUCT AND PANCREATIC DISORDERS | 2017 |
|
RU2740913C2 |
| ANTI-BAG2 ANTIBODY AND METHODS OF TREATING CANCER | 2020 |
|
RU2815586C2 |
| AGENT FOR THE TREATMENT OF DERMATOLOGICAL DISEASES | 2019 |
|
RU2799211C2 |
| BINDING PROTEINS AND METHODS FOR USE THEREOF | 2015 |
|
RU2701434C2 |
